| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ANTX | AN2 Therapeutics, Inc. | Easom Eric | Chief Executive Officer | Nov 18, 2024 | Buy | $1.00 | 50,000 | 49,970 | 1,065,766 | Nov 18, 2024, 08:51 PM | |
| ANTX | AN2 Therapeutics, Inc. | Easom Eric | Chief Executive Officer | Jan 02, 2024 | Sale | $20.09 | 2,777 | 55,802 | 2,130 | Jan 04, 2024, 06:05 PM | |
| ANTX | AN2 Therapeutics, Inc. | Easom Eric | Chief Executive Officer | May 15, 2023 | Buy | $5.38 | 10,000 | 53,770 | 1,015,766 | May 15, 2023, 08:01 PM | |
| ANTX | AN2 Therapeutics, Inc. | Easom Eric | Chief Executive Officer | Nov 10, 2022 | Sale | $15.32 | 4,413 | 67,628 | 4,930 | Nov 14, 2022, 08:48 PM | |
| ANTX | AN2 Therapeutics, Inc. | Easom Eric | Chief Executive Officer | Nov 14, 2022 | Sale | $15.04 | 23 | 346 | 4,907 | Nov 14, 2022, 08:48 PM | |
| ANTX | AN2 Therapeutics, Inc. | Easom Eric | Chief Executive Officer | Nov 08, 2022 | Sale | $15.58 | 7,055 | 109,947 | 16,273 | Nov 09, 2022, 08:33 PM | |
| ANTX | AN2 Therapeutics, Inc. | Easom Eric | Chief Executive Officer | Nov 09, 2022 | Sale | $15.61 | 10,111 | 157,847 | 4,907 | Nov 09, 2022, 08:33 PM | |
| ANTX | AN2 Therapeutics, Inc. | Easom Eric | Chief Executive Officer | Nov 03, 2022 | Sale | $15.75 | 14,165 | 223,058 | 29,021 | Nov 07, 2022, 08:19 PM | |
| ANTX | AN2 Therapeutics, Inc. | Easom Eric | Chief Executive Officer | Nov 04, 2022 | Sale | $15.80 | 8,828 | 139,474 | 17,110 | Nov 07, 2022, 08:19 PM | |
| ANTX | AN2 Therapeutics, Inc. | Easom Eric | Chief Executive Officer | Nov 07, 2022 | Sale | $16.04 | 12,203 | 195,741 | 6,943 | Nov 07, 2022, 08:19 PM | |
| ANTX | AN2 Therapeutics, Inc. | Easom Eric | Chief Executive Officer | Oct 31, 2022 | Sale | $15.39 | 2,688 | 41,363 | 6,451 | Nov 02, 2022, 08:52 PM | |
| ANTX | AN2 Therapeutics, Inc. | Easom Eric | Chief Executive Officer | Nov 02, 2022 | Sale | $15.07 | 1,544 | 23,263 | 4,907 | Nov 02, 2022, 08:52 PM | |
| ANTX | AN2 Therapeutics, Inc. | Easom Eric | Chief Executive Officer | Oct 27, 2022 | Sale | $15.36 | 924 | 14,190 | 6,590 | Oct 28, 2022, 08:27 PM | |
| ANTX | AN2 Therapeutics, Inc. | Easom Eric | Chief Executive Officer | Oct 28, 2022 | Sale | $15.09 | 1,683 | 25,392 | 4,907 | Oct 28, 2022, 08:27 PM | |
| ANTX | AN2 Therapeutics, Inc. | Easom Eric | Chief Executive Officer | Oct 26, 2022 | Sale | $15.10 | 1,678 | 25,342 | 4,907 | Oct 26, 2022, 09:19 PM | |
| ANTX | AN2 Therapeutics, Inc. | Easom Eric | Chief Executive Officer | Oct 24, 2022 | Sale | $16.17 | 2,866 | 46,344 | 11,391 | Oct 26, 2022, 09:19 PM | |
| ANTX | AN2 Therapeutics, Inc. | Easom Eric | Chief Executive Officer | Oct 25, 2022 | Sale | $15.75 | 4,806 | 75,672 | 7,119 | Oct 26, 2022, 09:19 PM | |
| ANTX | AN2 Therapeutics, Inc. | Easom Eric | Chief Executive Officer | Oct 20, 2022 | Sale | $16.68 | 7,293 | 121,672 | 18,889 | Oct 24, 2022, 09:44 PM | |
| ANTX | AN2 Therapeutics, Inc. | Easom Eric | Chief Executive Officer | Oct 21, 2022 | Sale | $16.36 | 13,951 | 228,240 | 7,257 | Oct 24, 2022, 09:44 PM |
Menu